Main Topic: The current pediatric care crisis in the US due to the surge in RSV (respiratory syncytial virus) cases, and the development of new vaccines to combat the virus.
Key Points:
Participants:
Takeaways:
Sean Rameswaram
A lot of kids in America are sick right now. There's the flu. There's still that lingering pandemic. But the big problem appears to be RSV, respiratory syncytial virus. Authorities say it is the worst pediatric care crisis in decades.
Pause
Well, here's an alarming number. 99% of pediatric beds are now full at one of the nation's top hospitals. I'm worried about the kids getting sicker and the lack of beds, being able to fit them all in for the care that they need.
Pause
And it is a virus very well known to all of us, whether you realize it or not. It is an extremely common cause of colds every cold season. But for babies, this is no common cold. It's critical. And this has been a particularly brutal year.
Pause
The hospitals are at or above capacity and the emergency departments are seeing double volumes from what they were ever seeing before COVID. But it's not all bad news. We might have some viable vaccines. The details are forthcoming on Today Explained.
Pause
Support for Today Explained comes from BetterHelp. Let me tell you a true story. Last weekend, I got an email from a listener who wanted to discuss their problems with me. And I said, look, I don't think that this is about me personally. At least I hope it's not. Why don't you try betterhelp.com slash explained? Absolute truth.
Pause
As the largest online therapy provider in the world, BetterHelp can provide access to mental health professionals with a diverse variety of expertise. Find the one with BetterHelp. The one is not me, guys. Our listeners get 10% off their first month at BetterHelp.com. That's BetterHelp.com.
Pause
Why shop at Burlington? Maybe it's the deals that are new each time you drop by. Maybe it's the brand names you'll be shocked Burlington has in store. Or maybe it's the quality of the items, the amazing selection, and the newest trends.
Pause
If you like to save but also like to stay in style, Burlington is your answer. And the question you'll be asking yourself is, why go anywhere else? Burlington. Deals. Brands. Wow.
Pause
Today Explained, Sean Rameswaram firm here with Vox's Dr. Karen Landman, who has some gnarly details about RSV to kick off the show.
Pause
Dr. Karen Landman
Yeah, once you see it, you never forget it. The main thing that RSV does is it attacks the lining of the airways. And that leads to inflammation, so thickening of those airways. And in response, your immune system makes a lot of mucus, which basically further narrows the airways.
Pause
It started out with just cold and all of a sudden it just was gunked up and couldn't breathe. And it's almost like if you take a thin plastic straw and now because of the inflammation, it's suddenly made of this thick cardboard. And not only that, because it's got all this junk on the inside, it's like there's peanut butter on the inside.
Pause
So try to move air through a peanut butter-lined cardboard straw. It's going to go a lot. It's going to take a lot more effort to move that air than it will if you have that, you know, a thin plastic straw. Sorry, that's kind of gross.
Pause
Sean Rameswaram
What a haunting visual, Karen. You're welcome.
Pause
Dr. Karen Landman
The difference between kids and adults when it comes to respiratory viruses is the size of their airways. In babies, they both start and end much, much, much smaller than they do in adults.
Pause
So anything that thickens that airway and narrows the space through which air moves is going to have a more severe impact on a baby just because your starting size of that tube is so much smaller than it is in adults.
Pause
And so these babies cough, they make this like terrible hacking, juicy cough. And then they also wheeze a lot or what sounds like wheezing a lot because they're moving air through just a much, much narrower space.
Pause
It makes a kind of whistling, wheezy noise. Her rib cage very clearly when she was doing every single breath, it was going in and out, in and out.
Pause
They work to move the air through their airways much harder than they would if their airways were not clogged like this. So that looks different in babies and adults because there's so much more cartilage in the rib cages.
Pause
So you really see them sucking in the spaces between their ribs, sometimes denting in the fronts of their chest, just above their belly, just because their chests are working so hard to try to get their little lungs to fill with air.
Pause
We were definitely terrified, especially when we saw that she needed to go on oxygen and had the tubes in her nose. I did not think RSV could do this to babies. Like, I did not know that they could be intubated, that they could almost die, that they could code.
Pause
It's really alarming to see for parents and even for health care providers, even the ones that have seen a lot of sick babies, RSV babies just look like they're really struggling. It's hard to watch.
Pause
And all peanut butter aside, this can kill these infants. It is killing these infants. It kills lots of infants. I mean, in the U.S., where we have pretty great pediatric care are other many, many issues of access and equity notwithstanding.
Pause
We lose 100 to 300 babies a year to RSV, which is a lot, actually. Babies should not be dying of infections like this. But globally, you know, this disease causes many, many more pediatric deaths just because they do not have access to the kind of respiratory support, the kinds of machines and medications and care that we do here in the United States.
Pause
You know, the estimates vary depending on who's doing the math and how exactly they do it. But it's upward of 100,000 babies per year that die globally of RSV and probably closer to 120,000 to 150,000 babies a year.
Pause
It also causes lots of illness that leads, quote, only to hospitalization, which is also not great. We hospitalize about around 60,000 babies a year in the United States. And being hospitalized, as any parent of a small baby will tell you, it's super stressful.
Pause
It's also, you know, it's just not a situation that anybody wants to have their baby hospitalized. So those are important as well. But it's also a very, very important cause of hospitalization and death in adults.
Pause
You know, we really don't recognize RSV as much as we should as a cause of pneumonia in adults. But in people over 65, we hospitalized 120,000 a year in the United States for RSV-related causes. and many die as well
Pause
It has a huge impact. Why are kids getting so sick right now if this has been around forever? What feels different about 2022?
Pause
What a lot of folks think is going on is that RSV just hasn't had a chance to circulate at the rate that it's now circulating for a long time.
Pause
Even though kids went back to school last fall, and there was a big surge of RSV last fall to go along with that, adults were still masked and a lot of them were still not back physically in the office.
Pause
So what's happening now is that not only are kids back in school, but adults are also circulating and mostly unmasked.
Pause
So RSV, it circulates pretty widely every fall. And a lot of people get infected with RSV every year, sometimes multiple times a year.
Pause
And that kind of leaves them with a level of antibodies that can prevent subsequent RSV infections from being super, super severe.
Pause
If you go several years without an RSV infection, antibody level wanes down to the point where your immune system, when it sees RSV again, it's like it's the first time all over again.
Pause
And so it responds more strongly to that infection. So we now have also, when you think about it, babies who were born during the pandemic, a lot of them never got exposed to any cold because they've been either kept home or masked.
Pause
Or they've just been in environments where they have not gotten a lot of exposure to those things, to viruses. So they haven't had a chance to build any immunity.
Pause
So new infections now, whether RSV or not, are meeting immune systems that really don't have a lot of protection against them or much experience with them.
Pause
Sean Rameswaram
What is the impact right now of this surge on the health care system?
Pause
Dr. Karen Landman
The impact right now is largely unfolding in children's hospitals or on pediatric wards of general hospitals.
Pause
A lot of those hospital beds are full. A lot of the ICUs are full. The intensive care units are really close to capacity.
Pause
And most importantly, a lot of emergency rooms are full and beyond full.
Pause
I talked to the COO of Children's Hospital of Alabama, which is the only children's hospital in that state, the other day.
Pause
And he said that where they usually have they have 52 spaces in their beds in their emergency room to see kids.
Pause
And they had 125 people physically in the emergency room a few nights ago.
Pause
And that means that 70 odd people are waiting to be seen at any given moment.
Pause
Sean Rameswaram
And that's a really bad scene, as you can imagine, in an emergency room that's just not equipped for that.
Pause
Dr. Karen Landman
It doesn't necessarily mean that a larger proportion of the people in the emergency room are sick, but it does mean that if you show up with a broken arm or with something else that's not RSV, you're going to wait a lot longer to get care.
Pause
And if you happen to be somebody whose illness is moving quickly and you're getting sick more quickly, it's not a super safe place for you.
Pause
Sean Rameswaram
So when you have your kid wheezing, really fighting for air, and you know that the respiratory person has like 60 other kids they have to deal with, it's a painful process, a helpless process.
Pause
As we learned in COVID, your health care system is only as strong as the people who are able to staff it.
Pause
You can have 100 beds in the hospital, but if you only have enough nurses and respiratory therapists and doctors to take care of 80 patients, you functionally only have 80 beds.
Pause
We already had a pretty strained health care staffing system before COVID, but 20% of health care workers either quit or were laid off during the earlier parts of the pandemic.
Pause
And a lot of those folks are not coming back to bedside patient care.
Pause
And that means that as stressed as our healthcare workforce was before the pandemic, it's much more strained now.
Pause
So there's just a lot less slack in the system to handle surges like this.
Pause
Where in the past there was a pool of, for example, travel nurses that could very easily be flexed on during a seasonal surge like this, almost like any other seasonal worker that you could hire and then not keep on staff for the rest of the year when you didn't need them.
Pause
That pool just no longer exists. If it exists, it's a lot smaller.
Pause
So there's just a lot less reserve, a lot less ability to scale up our health care workforce when we need it during surges like this.
Pause
And that is in large part, not entirely, but in large part a consequence of the pandemic.
Pause
But is this surge we're experiencing right now forcing people to take this a little more seriously this year?
Pause
Dr. Karen Landman
This is the first time that I've seen RSV in the headlines to the degree that it is now.
Pause
And I hope that people will take it more seriously as a consequence.
Pause
And I think equally importantly, even though the general public may not take RSV seriously, the medical community really does.
Pause
And that's a good thing because they've been working on some really important solutions to RSV and have been for years, really decades.
Pause
There's some really exciting stuff coming down the pike.
Pause
Pfizer just releasing data on trials for a shot for pregnant women to combat the respiratory illness that is hitting children so hard nationwide.
Pause
Pfizer plans to submit the vaccine for FDA approval. By the end of the year, the vaccine is given as a single dose shot.
Pause
Sean Rameswaram
Really incredible advances along prevention lines that I think are going to be real game changers for RSV's effect on babies and adults, both in the U.S. and globally.
Pause
We love a little hope, Karen. Yes, hope is good.
Pause
Support for Today Explained comes from Chime.
Pause
Nobody likes fees and complicated banking, says Chime. And Chime gets that, says Chime.
Pause
Chime is a financial technology company that says they understand that every dollar counts.
Pause
So when you set up direct deposit through Chime, they say you get access to fee-free features, such as free overdraft coverage, getting paid up to two days early with direct deposit, so much more.
Pause
Chime says with qualifying direct deposits, you can be eligible for free overdraft, up to $200 on debit card purchases and cash withdrawals.
Pause
Plus, they say you don't need to worry about monthly fees or maintenance fees.
Pause
You can work on your financial goals through Chime today.
Pause
You can open an account in two minutes at Chime slash explained.
Pause
That Chime slash explained.
Pause
Chime feels like progress.
Pause
Chime is a financial technology company not a bank.
Pause
Banking services and debit card provided by the Bancorp Bank N or Stride Bank N.A.
Pause
Members FDIC.
Pause
Spot me eligibility requirements and overdraft limits apply.
Pause
Timing depends on submission of payment file.
Pause
Fees apply at out-of-network ATMs.
Pause
Bank ranking and number of ATMs according to U.S. News and World Report 2023.
Pause
Chime checking account required.
Pause
Imagine fast hydration Combined with balanced energy Perfectly flavored with zero artificial sweeteners Introducing Liquid IV's new energy multiplier sugar-free Unlike other energy drinks You know, the ones that make you feel like you're glitching
Pause
It's made with natural caffeine and electrolytes So you get the boost without the burnout Liquid IV's new energy multiplier sugar-free hydrating energy.
Pause
Tap the banner to learn more.
Pause
Today Explained, still here with Karen Landman.
Pause
Dr. Karen Landman
Karen, you mentioned a moment ago that there's good news here. There are some vaccine trials.
Pause
We recently got some news. Why isn't there already a vaccine for RSV?
Pause
Oh, Sean, it's a long story.
Pause
It starts back in the 1960s with an effort to create an RSV vaccine, which really speaks of just for how long RSV has been a scourge on the scene of pediatric illnesses.
Pause
A bunch of scientists tried to create a vaccine. It didn't go well.
Pause
The kids who received the vaccine and then got infected through the course of their lives with RSV actually did worse than the kids who didn't get the vaccine.
Pause
And two of the kids who got the vaccine died.
Pause
Wait, how did these kids die?
Pause
Without getting too far into the weeds, basically, we didn't really understand how different babies' immune systems are from adults back then.
Pause
And the vaccine wasn't weakened enough, and it ended up causing these babies to have a stronger immune reaction to their RSV infections than they would have had without the vaccine.
Pause
We know a lot more about babies' immune systems now than we did back then.
Pause
But even over the next few decades after the 60s, just because there was so much fear after that failed vaccine trial, that it just really slowed vaccine development related to RSV for a really long time.
Pause
Sean Rameswaram
Does anything happen between then and now?
Pause
Dr. Karen Landman
Surely, yes. Yes, very much so.
Pause
So something really exciting happened in 2013 when a scientist named Jason McClellan, who's now at the University of Texas in Austin, figured out how to solve an important problem in RSV vaccine development.
Pause
Okay, so that's a bit of a story. We're trying to do a lot of work there for structure-based vaccine design for HIV-1.
Pause
And it was challenging and maybe because HIV is a really difficult virus.
Pause
So I thought, why don't we try and work on RSV, maybe a more tractable virus.
Pause
Basically, the issue was that RSV, when it's just circulating in your blood, before it actually invades a cell, the proteins on its surface, which would normally be a target for a vaccine, have a certain shape.
Pause
Once the virus invades your body's cells, those proteins take a different shape.
Pause
You really ideally want to target the pre-invasion shape of the virus proteins because that way you can actually have your body's immune system recognize the virus before it invades your cells, right?
Pause
But the problem is that when they would try to isolate this protein in the lab and get a look at its shape in this sort of pre-invasion, pre-fusion stage, it really was unstable.
Pause
And they just couldn't get it to sit still long enough for them to get a clear picture of what it looked like in order to create a vaccine to attack it.
Pause
But in 2013, McClellan figured out how to keep this protein stable enough in its pre-fusion, pre-invasion stage so that they could actually get a good enough sense of what it looked like to develop vaccines to prevent it.
Pause
And that was a huge step forward for this field.
Pause
So it really sparked an enormous amount of scientific breakthrough afterwards.
Pause
And it was hugely important for hastening the development of the COVID vaccine once SARS-CoV-2 came on the scene.
Pause
This RSV research helped the COVID vaccine? Crazy, right?
Pause
We started working on the structure. They began coordinating with Moderna to get the first vaccine formulated.
Pause
Same basic principle. The spike protein on the surface of the virus that causes COVID is also not super stable in its pre-fusion phase.
Pause
And they needed to find a way to stabilize that in order to make a vaccine to target it.
Pause
So vaccine developments made in an effort to target one particular pathogen are really portable to efforts to target vaccines to other pathogens.
Pause
And this was a really exciting example of that.
Pause
Sean Rameswaram
How does this 2013 development set us up for the most recent development, which is that there's this new Pfizer vaccine candidate?
Pause
Dr. Karen Landman
This 2013 development actually set us up for a whole bunch of new vaccine candidates and other products that are coming on the scene to help protect both babies and adults from RSV.
Pause
Novavax Prepare Phase 3 trial of the RSVF vaccine for infants via maternal immunization aims to protect infants when they are most vulnerable to an RSV infection.
Pause
And the Pfizer vaccine candidate is just one of those.
Pause
But it's an important one because it's probably going to be the one that gets used most often, at least in the early stages of this.
Pause
Pfizer saying its vaccine against the respiratory virus is safe for pregnant women and effective in helping protect their babies.
Pause
This vaccine targets the pre-fusion, pre-invasion protein on the surface of RSV meant to be given to people who are carrying pregnancies in order to allow the antibodies that are stimulated by the vaccine to be transferred naturally to the fetus, to the baby that's inside during the pregnancy.
Pause
Fancy. It's not as uncommon as you might think. There are a lot of vaccines that are given to pregnant people with the express purpose of boosting antibody production so that those antibodies get transferred to the baby that they carrying before the baby is born in order to protect the baby from a whole variety of infections in case they exposed to them in the very early months of life.
Pause
Flu vaccine, COVID vaccine. We give other vaccines during pregnancy for this exact same reason.
Pause
And this is the way I think most babies will end up being protected from RSV.
Pause
And the reason we do that is because babies' immune systems are much, much less mature than even younger children's are.
Pause
They're just not capable of producing a lot of antibodies in the first few months of life.
Pause
So they really rely on the antibodies that they get from the person who carries them while they're pregnant.
Pause
Sean Rameswaram
How well does it work?
Pause
Dr. Karen Landman
In the trial results that Pfizer released early last week, the vaccine prevented 69% of severe RSV cases in babies six months and younger.
Pause
It is really nice.
Pause
So what we mean by severe cases are cases requiring medical attention.
Pause
So anything where a parent said, oh, this is too scary. I'm taking this kid into the clinic, to the hospital, to the doctor's office.
Pause
So that's actually a lot because that means that it's also preventing a lot of hospitalizations and also a fair amount of deaths.
Pause
Sean Rameswaram
So that's actually a big deal.
Pause
And this is just one of several RSV vaccines in development?
Pause
Dr. Karen Landman
Right. And I want to be clear when we say vaccines, it's not just vaccines that are being developed.
Pause
This maternal vaccine is, I think, the chief candidate for a maternal vaccine that's out there right now.
Pause
But there are also at least three monoclonal antibodies under development.
Pause
Some of us might remember hearing about monoclonal antibodies during COVID.
Pause
I caught it. I heard about this drug. I said, let me take it. It was my suggestion. I said, let me take it. And it was incredible the way it worked.
Pause
Incredible. It's basically a synthetic version of the naturally produced antibody that you get when you get vaccinated.
Pause
This will primarily be used in babies who are born before the person carrying them has a chance to get vaccinated with a maternal RSV vaccine.
Pause
So say your baby is born at 30 weeks before you had a chance to get an RSV vaccine or you weren't able to get prenatal care.
Pause
Your baby can still get monoclonal antibody instead of the antibodies that the parent would have passed on to them and still be really well protected in those first six months of life when, I should also mention, RSV is most dangerous.
Pause
Sean Rameswaram
Okay, you've got the Pfizer vaccine, a whole bunch of other ones. When do one of these things get approved?
Pause
Dr. Karen Landman
Is it Operation Warp Speed Part 2?
Pause
Oh, Sean. LOL. No, my sweet summer child.
Pause
Operation Warp Speed is not going to happen again for a long time.
Pause
We'd all love to see that kind of government investment in vaccines.
Pause
But that was a rare event for our government to fund vaccine development to that degree.
Pause
So this is... Even with dying babies? Yeah. Sorry.
Pause
You know, what Operation Warp Speed did was it scaled up the discovery process in a way that RSV vaccine doesn't really need.
Pause
What RSV vaccine needs now is, you know, approval and licensing and recommendations in the U.S.
Pause
And Pfizer's vaccine is already at a place where they are going to be submitting their data to the FDA for their review in the coming months, probably in the coming weeks even.
Pause
And that means that the pathway to scaling up production to make it available to parents carrying babies to protect their babies could happen in the next one to two years.
Pause
Sean Rameswaram
That's really exciting.
Pause
The monoclonal antibodies are probably also on a similar time course.
Pause
There are a couple of vaccines that are under investigation. I should call them vaccine candidates that are under investigation to be used in babies directly.
Pause
So these would look a little bit more like the vaccines that adults are used to, meaning vaccines that you get in your arm and they protect you rather than the kind that a parent gets to protect their infant.
Pause
And then there are all these vaccine candidates in adults, one of which I think is also on track to be approved in the next year or two.
Pause
So these are these are going to be moving forward, funded by pharma themselves to do a lot of work on getting approved, licensed and recommended and then have production scaled up.
Pause
And in the meantime, Karen, what do parents who are freaking out about this surge in RSV plus COVID plus the flu season do to protect their kids?
Pause
Dr. Karen Landman
We've learned a lot of lessons from COVID, right, about what it takes to reduce the spread of a respiratory virus.
Pause
These measures may not be extremely popular because so many of us are so tired of them, but they really work.
Pause
Washing your hands, right? Ventilating your spaces and wearing masks.
Pause
Like wearing masks when people are sick or when you're in crowded spaces.
Pause
It really works to protect kids and adults from these infections.
Pause
Sean Rameswaram
So a lot of the skills that we learn to keep each other healthy during COVID are applicable now and not just when it's COVID that's surging, but also when things like RSV are surging.
Pause
So I hope we can apply some of those lessons. to this current health crisis.
Pause
Dr. Karen Landman writes about science and health at Vox.
Pause
Our show today was produced by Victoria Chamberlain.
Pause
She had help from Matthew Collette, Laura Bullard, and Paul Robert Mounsey.
Pause
It's Today Explained. Thank you.
Pause
Emily by Anna